-
Diuron: From Photosynthesis to Renal Toxicology
2026-09-11
Diuron is more than a photosynthesis inhibitor: it is a useful model for connecting herbicide mechanism of action with kidney toxicology. This article presents an evidence-based framework for selecting endpoints, controlling exposure variables, and interpreting cross-domain assays.
-
Ciprofloxacin Hydrochloride Research Workflows
2026-09-10
Ciprofloxacin hydrochloride supports more than routine antibacterial testing: it can serve as a DNA-replication-inhibition benchmark, a comparator in antiparasitic screening, and a probe for immune and stress-response models. This practical guide connects mechanism, assay design, solution handling, and troubleshooting to improve reproducibility across cell, bacterial, and translational workflows.
-
ONX-0914 (PR-957) Experimental Workflow
2026-09-10
Build reproducible immunoproteasome experiments around ONX-0914 (PR-957), from LMP7-selective cytokine assays to mechanistic antiviral studies. The workflow emphasizes concentration control, orthogonal readouts, and careful separation of established evidence from application-focused recommendations.
-
iRhom2 in Olfaction: OR Regulation and Adaptation
2026-09-09
Azzopardi and colleagues identify iRhom2 as an olfactory sensory neuron factor that links odorant receptor activity with transcriptional adaptation. Using knockout mice, transcriptomics, spatial validation, and a receptor stimulation model, the study supports an iRhom2/ADAM17-associated pathway while also defining important limits on causal interpretation.
-
Acetoacetic Acid Sodium Salt in Cell Assays
2026-09-09
Learn how Acetoacetic acid sodium salt (SKU A9940) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing metabolic perturbation with assay failure. This scenario-based guide covers formulation, controls, protocol optimization, interpretation, and reagent selection using documented purity and solubility data.
-
Budesonide for Airway Inflammation Research
2026-09-08
Budesonide supports controlled asthma inflammation models, glucocorticoid-response studies, and membrane-permeability workflows. This guide connects practical cell-based assay design with IAM LC and LEKC insights to improve dose selection, interpretation, and troubleshooting in respiratory disease research.
-
Ionomycin Free Acid for FAK–TNBC Calcium Studies
2026-09-08
Ionomycin free acid provides a controlled way to examine calcium ion transport alongside the FAISL–FAK axis in triple-negative breast cancer research. This article translates the reference study into practical assay decisions while defining what calcium perturbation can—and cannot—demonstrate.
-
DHHC9–STRN4 Palmitoylation in YAP-Driven Metastasis
2026-09-07
The reference study identifies a DHHC9–STRN4 palmitoylation–YAP signaling axis that promotes adenocarcinoma migration and metastasis. Its combination of genetic, proteomic, functional, and small-molecule evidence positions DHHC9 as a mechanistically defined target for cancer research while highlighting the validation needed before pharmacological translation.
-
ac4C–Gm26917 Control of Translation in FGSCs
2026-09-05
This Advanced Science study identifies an ac4C–Gm26917–EEF1A1–Rpl10 pathway that links long noncoding RNA modification to ribosome-associated translation control in female germline stem cells. Its integrated use of acRIP-seq, RIC-seq, and ribosome profiling shows that ac4C supports Gm26917 stability and spatial engagement with Rpl10, thereby sustaining protein synthesis and stem-cell maintenance.
-
GLI2, WNT, and Resistance to Cancer Immunotherapy
2026-09-05
DeVito et al. identify GLI2 as a mechanistic coordinator of mesenchymal transformation, WNT ligand production, prostaglandin signaling, and immune checkpoint blockade resistance. The study suggests that disrupting GLI2-associated immune suppression or its downstream WNT and EP2/EP4 pathways could guide rational combination strategies, while also highlighting the need for clinical validation.
-
JNJ-26854165 Assay Workflows for p53 Research
2026-09-04
Build more informative Serdemetan studies by separating growth arrest from true cell killing and by aligning endpoint timing with mechanism. This workflow covers formulation, p53-aware controls, apoptosis confirmation, and radiation-response experiments from plate-based assays to tumor xenograft interpretation.
-
WZ4003: NUAK1/2 Inhibitor Workflows
2026-09-04
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase target engagement with changes in MYPT1 phosphorylation, cell-cycle progression, migration, invasion, and tau biology. This practical guide shows how to build controlled workflows, interpret cross-model results, and troubleshoot solubility, toxicity, and assay-specific confounders.
-
Deferasirox Workflows for Iron-Stress Research
2026-09-03
Deferasirox combines oral iron-chelation relevance with a practical in vitro platform for studying iron availability, mitochondrial ROS, lysosomal stress, and cell fate. This workflow translates the TCF25–V-ATPase findings from a recent Cell Reports study into testable assay designs while clearly separating established evidence from forward-looking hypotheses.
-
Troglitazone: PPARγ Agonist Research Workflows
2026-09-03
Troglitazone is a dual PPARγ/α pathway tool for connecting metabolic signaling with macrophage and renal carcinoma assays. This guide translates SPP1-focused tumor-myeloid research into practical dose-finding, co-culture, viability, and troubleshooting workflows without overstating Troglitazone as the lead compound from the reference study.
-
Vernakalant for Rapid Atrial Fibrillation Conversion
2026-09-02
This phase 3 randomized trial evaluated vernakalant hydrochloride, an atrium-selective ion-channel blocker, for rapid pharmacological conversion of atrial fibrillation. Vernakalant converted substantially more cases of short-duration atrial fibrillation than placebo, with a median conversion time of 11 minutes, while also highlighting the need for careful monitoring of hypotension and conduction-related adverse events.